XPndAI builds AI for drug discovery support, regulatory document intelligence, pharmacovigilance automation, and custom software for pharma companies and CROs.
End-to-end AI and software engineering with measurable enterprise outcomes.
AI pipelines for automated adverse event detection from case narratives, medical literature, and social media feeds for post-market surveillance.
Intelligent extraction and compilation from CTD modules, clinical study reports, and dossier submissions for regulatory affairs teams.
RAG-powered AI agents that let medical representatives and HCPs query product monographs, clinical data, and drug interaction databases instantly.
AI-assisted analysis of clinical trial datasets — anomaly detection, statistical summaries, and narrative report generation for CROs.
AI monitoring for GMP compliance, batch record review, deviation classification, and CAPA recommendation in pharma manufacturing.
Custom sales force effectiveness tools: territory management, doctor targeting, call reporting, and AI-generated territory insights for MRs.
A mid-size pharma company built a regulatory document AI that extracts and structures data from clinical study reports, maps it to CTD sections, and auto-populates submission templates — reducing regulatory dossier preparation time significantly.
A pharma major deployed a RAG-powered drug information agent for their medical representative training program. MRs can query the approved product monograph and clinical data in natural language during field calls — improving scientific engagement with HCPs.
Everything you need to know before starting an AI project with XPndAI.
Talk directly to our lead engineers. We audit your requirements, propose the exact architecture, and give you a transparent roadmap — all in one call.